January 19, 2023. Pensacola, FL— Regenative Labs (Regenative), a leading HCT/P manufacturer, announces a retrospective analysis of patients who have… Read More >
January 9, 2023, Pensacola, FL— Regenative Labs (Regenative), a leading HCT/P manufacturer has published a case study in the Journal… Read More >
This month marks five years since the FDA HCT/P regulations were first introduced. In that time we have (1) produced… Read More >
We know physicians drive innovation in medicine, and we are dedicated to our data-driven, outcomes-focused approach to advance this field… Read More >
PENSACOLA, Fla., Aug. 22, 2022 PENSACOLA, Fla., Aug. 22, 2022 /PRNewswire/ — Regenative Labs, a leading HCT/P manufacturer, has co-authored… Read More >
This includes the analogous nature of articular cartilage, muscle fascia, and intervertebral disc confirmed by way of comparative Scanning Electron… Read More >
Future applications for the early, preventative use of amniotic membrane allografts in addition to the current standard of care for… Read More >
PENSACOLA, Fla., Aug. 1, 2022 /PRNewswire/ — Regenative Labs, a leading HCT/P manufacturer, and AAPC, the nation’s largest medical coding, training, and… Read More >
Regenative Labs CEO predicts this will have significant implications to advance multiple fields. PENSACOLA, Fla., July 8, 2022 /PRNewswire/ —… Read More >
Regenative Labs to-date produces the first and only Wharton’s jelly allograft to be recognized as a 361 HCT/P by any… Read More >